German drugs and chemicals firm Merck KGaA (MKGAY.PK) reported a narrower second-quarter 2012 loss after tax of 60.5 million euros, compared with 86.8 million euros last year. On a reported basis, quarterly loss per share was 0.29 euros, narrower than a 0.41 euros loss a year before, the company added. Adjusted for one-time costs, earnings per share pre totaled 1.92 euros, up 20% from the prior year's 1.60 euros.
Merck's second-quarter total revenues rose 12% to 2.85 billion euros, from 2.555 billion euros in the 2011 second quarter. Quarterly sales went up 11% to 2.74 billion euros, from 2.47 billion euros in the year-ago quarter, reflecting an organic sales growth of 5.1%, a 5.4% positive benefit from foreign exchange rates and a 0.5% rise from acquisitions and divestments.
Based on the second-quarter results, Merck has upgraded its full-year total revenues and EBITDA pre guidance for 2012. The company now sees annual EBITDA pre one-time items of 2.85 billion euros - 2.95 billion euros, and total revenues of around 10.7 billion euros. Previously, Merck Group estimated EBITDA pre one-time items of 2.8 billion euros - 2.9 billion euros, and total revenues of about 10.5 billion euros for 2012.
Click here to receive FREE breaking news email alerts for Merck KGaA and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com